October 17, 2011

Dr. Nicholas M. Barbaro has been named chairman of the department of neurological surgery at the Indiana University School of Medicine and the first medical director of the new Indiana University Health Neurosciences Center of Excellence. Barbaro will join IU on Nov. 1 after departing the University of California-San Francisco medical school, where he oversees neurosurgery residents and is conducting a federally funded study of epilepsy. Barbaro will succeed Dr. Paul Nelson, who is retiring.

Tom Laux will step down in March as CEO of Indiana University Health Morgan Hospital in Martinsville. Laux has led the county-owned hospital since 1999 and engineered its merger with Indianapolis-based IU Health.

Dr. Bill VanNess will retire at the end of 2012 as CEO of Community Hospital Anderson. VanNess, an Anderson native and family physician, has led the hospital, which is affiliated with Indianapolis-based Community Health Network, since 1997.

Bryce Carmine, president of Eli Lilly and Co.’s bio-medicines division, and Frank Deane, president of Lilly’s global manufacturing operations, both will retire on Dec. 31. They have worked at the Indianapolis-based drugmaker for 36 and 33 years, respectively. Dave Ricks, president of Lilly’s U.S. subsidiary, will become chief of the bio-medicines unit. That division oversees sales in the United States, Europe and Japan of some of Lilly’s most lucrative drugs, including the antipsychotic Zyprexa, the antidepressant Cymbalta and the anti-impotence pill Cialis. Succeeding Deane will be Maria Crowe, now senior vice president for global drug product manufacturing. Lilly also announced that Alex Azar, its vice president of U.S. managed health care services, will replace Ricks as head of Lilly USA.